Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
948 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
CD36 molecule |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
CD36 |
SynonymsGene synonyms aliases
|
BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 |
ChromosomeChromosome number
|
7 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
7q21.11 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs1049673 |
C>G,T |
Risk-factor |
3 prime UTR variant, genic downstream transcript variant |
rs1527483 |
G>A |
Risk-factor |
Intron variant |
rs1761667 |
G>A |
Risk-factor |
Genic upstream transcript variant, intron variant |
rs1984112 |
A>C,G,T |
Risk-factor |
Genic upstream transcript variant, intron variant |
rs3211893 |
T>A,C,G |
Likely-pathogenic |
Splice donor variant |
rs3211938 |
T>G |
Risk-factor, pathogenic, benign |
Coding sequence variant, stop gained, intron variant |
rs70961716 |
AAAA>-,AAAAA |
Likely-pathogenic |
Frameshift variant, intron variant, coding sequence variant |
rs75326924 |
C>T |
Pathogenic |
Intron variant, 5 prime UTR variant, non coding transcript variant, missense variant, coding sequence variant |
rs121918035 |
A>C,G |
Pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs142186404 |
T>C,G |
Pathogenic |
Non coding transcript variant, intron variant, coding sequence variant, missense variant |
rs148051111 |
G>A,C |
Likely-pathogenic, uncertain-significance |
Splice donor variant |
rs148910227 |
C>G,T |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs550565800 |
ATTGTGCCTATT>-,ATTGTGCCTATTGTGCCTATT |
Pathogenic-likely-pathogenic |
Inframe deletion, inframe insertion, coding sequence variant, non coding transcript variant |
rs551607784 |
G>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant, non coding transcript variant |
rs572295823 |
CA>- |
Pathogenic |
Coding sequence variant, 5 prime UTR variant, frameshift variant, non coding transcript variant |
rs765809606 |
A>-,AA |
Pathogenic |
Non coding transcript variant, coding sequence variant, frameshift variant |
rs766920034 |
->C |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, intron variant, frameshift variant |
rs771061715 |
AATAA>- |
Likely-pathogenic |
Non coding transcript variant, terminator codon variant, frameshift variant |
rs1064795310 |
G>C |
Likely-pathogenic |
Splice acceptor variant |
rs1064795836 |
G>C |
Likely-pathogenic |
Splice donor variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IEA |
|
GO:0001540 |
Function |
Amyloid-beta binding |
IC |
20037584 |
GO:0001540 |
Function |
Amyloid-beta binding |
IDA |
29518356 |
GO:0001540 |
Function |
Amyloid-beta binding |
TAS |
20037584 |
GO:0001954 |
Process |
Positive regulation of cell-matrix adhesion |
IDA |
17416590 |
GO:0002224 |
Process |
Toll-like receptor signaling pathway |
TAS |
|
GO:0002479 |
Process |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
TAS |
|
GO:0002532 |
Process |
Production of molecular mediator involved in inflammatory response |
TAS |
29111364 |
GO:0002576 |
Process |
Platelet degranulation |
TAS |
|
GO:0002755 |
Process |
MyD88-dependent toll-like receptor signaling pathway |
TAS |
|
GO:0005041 |
Function |
Low-density lipoprotein particle receptor activity |
IBA |
21873635 |
GO:0005041 |
Function |
Low-density lipoprotein particle receptor activity |
IMP |
10772654 |
GO:0005041 |
Function |
Low-density lipoprotein particle receptor activity |
TAS |
9568716 |
GO:0005044 |
Function |
Scavenger receptor activity |
IBA |
21873635 |
GO:0005044 |
Function |
Scavenger receptor activity |
IMP |
18941241 |
GO:0005044 |
Function |
Scavenger receptor activity |
TAS |
11240025, 29111364 |
GO:0005324 |
Function |
Long-chain fatty acid transporter activity |
IMP |
21395585 |
GO:0005515 |
Function |
Protein binding |
IPI |
16880211, 18773118, 20037584, 23640500, 32814053 |
GO:0005615 |
Component |
Extracellular space |
HDA |
16502470 |
GO:0005737 |
Component |
Cytoplasm |
IBA |
21873635 |
GO:0005794 |
Component |
Golgi apparatus |
IDA |
16880211 |
GO:0005886 |
Component |
Plasma membrane |
IBA |
21873635 |
GO:0005886 |
Component |
Plasma membrane |
IDA |
22022213, 24503477 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
|
GO:0005887 |
Component |
Integral component of plasma membrane |
TAS |
9568716 |
GO:0005901 |
Component |
Caveola |
IBA |
21873635 |
GO:0006629 |
Process |
Lipid metabolic process |
NAS |
7518447 |
GO:0006631 |
Process |
Fatty acid metabolic process |
TAS |
29111364 |
GO:0006898 |
Process |
Receptor-mediated endocytosis |
IBA |
21873635 |
GO:0006898 |
Process |
Receptor-mediated endocytosis |
IMP |
18941241 |
GO:0006898 |
Process |
Receptor-mediated endocytosis |
TAS |
|
GO:0006910 |
Process |
Phagocytosis, recognition |
IEA |
|
GO:0006911 |
Process |
Phagocytosis, engulfment |
TAS |
29111364 |
GO:0007155 |
Process |
Cell adhesion |
IEA |
|
GO:0007204 |
Process |
Positive regulation of cytosolic calcium ion concentration |
ISS |
|
GO:0007263 |
Process |
Nitric oxide mediated signal transduction |
IDA |
17416590 |
GO:0007596 |
Process |
Blood coagulation |
TAS |
2468670 |
GO:0008035 |
Function |
High-density lipoprotein particle binding |
IEA |
|
GO:0008289 |
Function |
Lipid binding |
IDA |
10772654 |
GO:0009897 |
Component |
External side of plasma membrane |
IEA |
|
GO:0009986 |
Component |
Cell surface |
IBA |
21873635 |
GO:0009986 |
Component |
Cell surface |
IDA |
10772654 |
GO:0009986 |
Component |
Cell surface |
ISS |
|
GO:0009986 |
Component |
Cell surface |
TAS |
29111364 |
GO:0010628 |
Process |
Positive regulation of gene expression |
ISS |
|
GO:0010744 |
Process |
Positive regulation of macrophage derived foam cell differentiation |
IMP |
10772654 |
GO:0010886 |
Process |
Positive regulation of cholesterol storage |
IEA |
|
GO:0010942 |
Process |
Positive regulation of cell death |
IMP |
27607416 |
GO:0015636 |
Function |
Short-chain fatty acid transmembrane transporter activity |
IMP |
21395585 |
GO:0015909 |
Process |
Long-chain fatty acid transport |
IMP |
21395585 |
GO:0015911 |
Process |
Long-chain fatty acid import across plasma membrane |
IDA |
24503477 |
GO:0015912 |
Process |
Short-chain fatty acid transport |
IMP |
21395585 |
GO:0016020 |
Component |
Membrane |
TAS |
2468669 |
GO:0016324 |
Component |
Apical plasma membrane |
IEA |
|
GO:0019216 |
Process |
Regulation of lipid metabolic process |
TAS |
|
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
TAS |
|
GO:0019915 |
Process |
Lipid storage |
IBA |
21873635 |
GO:0019915 |
Process |
Lipid storage |
IMP |
10772654 |
GO:0019934 |
Process |
CGMP-mediated signaling |
IDA |
17416590 |
GO:0030169 |
Function |
Low-density lipoprotein particle binding |
IBA |
21873635 |
GO:0030169 |
Function |
Low-density lipoprotein particle binding |
IDA |
10772654 |
GO:0030194 |
Process |
Positive regulation of blood coagulation |
IEA |
|
GO:0030299 |
Process |
Intestinal cholesterol absorption |
ISS |
|
GO:0030301 |
Process |
Cholesterol transport |
ISS |
12376530 |
GO:0030666 |
Component |
Endocytic vesicle membrane |
TAS |
|
GO:0031092 |
Component |
Platelet alpha granule membrane |
TAS |
|
GO:0031526 |
Component |
Brush border membrane |
ISS |
|
GO:0031623 |
Process |
Receptor internalization |
ISS |
|
GO:0031664 |
Process |
Regulation of lipopolysaccharide-mediated signaling pathway |
TAS |
29111364 |
GO:0032611 |
Process |
Interleukin-1 beta production |
ISS |
|
GO:0032735 |
Process |
Positive regulation of interleukin-12 production |
IEA |
|
GO:0032755 |
Process |
Positive regulation of interleukin-6 production |
IEA |
|
GO:0032760 |
Process |
Positive regulation of tumor necrosis factor production |
IEA |
|
GO:0033993 |
Process |
Response to lipid |
ISS |
|
GO:0034121 |
Process |
Regulation of toll-like receptor signaling pathway |
IGI |
20037584 |
GO:0034197 |
Process |
Triglyceride transport |
ISS |
|
GO:0034381 |
Process |
Plasma lipoprotein particle clearance |
ISS |
12376530 |
GO:0034383 |
Process |
Low-density lipoprotein particle clearance |
IBA |
21873635 |
GO:0034383 |
Process |
Low-density lipoprotein particle clearance |
IMP |
10772654 |
GO:0035325 |
Function |
Toll-like receptor binding |
IPI |
20037584 |
GO:0035579 |
Component |
Specific granule membrane |
TAS |
|
GO:0035634 |
Process |
Response to stilbenoid |
IEA |
|
GO:0038124 |
Process |
Toll-like receptor TLR6:TLR2 signaling pathway |
TAS |
|
GO:0042308 |
Process |
Negative regulation of protein import into nucleus |
IEA |
|
GO:0042953 |
Process |
Lipoprotein transport |
IBA |
21873635 |
GO:0042953 |
Process |
Lipoprotein transport |
IMP |
10772654 |
GO:0042953 |
Process |
Lipoprotein transport |
TAS |
9568716 |
GO:0043123 |
Process |
Positive regulation of I-kappaB kinase/NF-kappaB signaling |
IEA |
|
GO:0043235 |
Component |
Receptor complex |
IPI |
20037584 |
GO:0043254 |
Process |
Regulation of protein-containing complex assembly |
IMP |
20037584 |
GO:0043277 |
Process |
Apoptotic cell clearance |
IEA |
|
GO:0043312 |
Process |
Neutrophil degranulation |
TAS |
|
GO:0044539 |
Process |
Long-chain fatty acid import into cell |
IBA |
21873635 |
GO:0044539 |
Process |
Long-chain fatty acid import into cell |
IDA |
17416590, 22022213 |
GO:0044877 |
Function |
Protein-containing complex binding |
IPI |
29518356 |
GO:0045121 |
Component |
Membrane raft |
IDA |
16880211 |
GO:0045335 |
Component |
Phagocytic vesicle |
TAS |
|
GO:0045429 |
Process |
Positive regulation of nitric oxide biosynthetic process |
ISS |
|
GO:0050431 |
Function |
Transforming growth factor beta binding |
ISS |
|
GO:0050731 |
Process |
Positive regulation of peptidyl-tyrosine phosphorylation |
IEA |
|
GO:0050830 |
Process |
Defense response to Gram-positive bacterium |
IEA |
|
GO:0050892 |
Process |
Intestinal absorption |
ISS |
|
GO:0050909 |
Process |
Sensory perception of taste |
ISS |
|
GO:0051092 |
Process |
Positive regulation of NF-kappaB transcription factor activity |
IGI |
20037584 |
GO:0055096 |
Process |
Low-density lipoprotein particle mediated signaling |
IEA |
|
GO:0060100 |
Process |
Positive regulation of phagocytosis, engulfment |
IEA |
|
GO:0060907 |
Process |
Positive regulation of macrophage cytokine production |
IEA |
|
GO:0070053 |
Function |
Thrombospondin receptor activity |
ISS |
|
GO:0070374 |
Process |
Positive regulation of ERK1 and ERK2 cascade |
ISS |
|
GO:0070508 |
Process |
Cholesterol import |
ISS |
|
GO:0070542 |
Process |
Response to fatty acid |
ISS |
|
GO:0070543 |
Process |
Response to linoleic acid |
ISS |
|
GO:0070892 |
Function |
Lipoteichoic acid immune receptor activity |
IEA |
|
GO:0071222 |
Process |
Cellular response to lipopolysaccharide |
IEA |
|
GO:0071223 |
Process |
Cellular response to lipoteichoic acid |
IEA |
|
GO:0071404 |
Process |
Cellular response to low-density lipoprotein particle stimulus |
ISS |
|
GO:0071447 |
Process |
Cellular response to hydroperoxide |
IEA |
|
GO:0071726 |
Process |
Cellular response to diacyl bacterial lipopeptide |
IDA |
16880211 |
GO:0071813 |
Function |
Lipoprotein particle binding |
IDA |
9568716 |
GO:0071944 |
Component |
Cell periphery |
IDA |
26449856 |
GO:0097009 |
Process |
Energy homeostasis |
ISS |
|
GO:0098900 |
Process |
Regulation of action potential |
ISS |
|
GO:0120162 |
Process |
Positive regulation of cold-induced thermogenesis |
ISS |
25596128 |
GO:0140052 |
Process |
Cellular response to oxidised low-density lipoprotein particle stimulus |
IMP |
27607416 |
GO:0150024 |
Process |
Oxidised low-density lipoprotein particle clearance |
IMP |
27607416 |
GO:0150025 |
Function |
Oxidised low-density lipoprotein particle receptor activity |
IMP |
27607416 |
GO:0150094 |
Process |
Amyloid-beta clearance by cellular catabolic process |
IBA |
21873635 |
GO:0150094 |
Process |
Amyloid-beta clearance by cellular catabolic process |
IMP |
18941241 |
GO:1900227 |
Process |
Positive regulation of NLRP3 inflammasome complex assembly |
ISS |
|
GO:1901480 |
Function |
Oleate transmembrane transporter activity |
IDA |
24503477 |
GO:1903428 |
Process |
Positive regulation of reactive oxygen species biosynthetic process |
ISS |
|
GO:1904646 |
Process |
Cellular response to amyloid-beta |
IGI |
20037584 |
GO:1990000 |
Process |
Amyloid fibril formation |
ISS |
|
GO:1990379 |
Process |
Lipid transport across blood-brain barrier |
IMP |
21395585 |
GO:2000121 |
Process |
Regulation of removal of superoxide radicals |
IEA |
|
GO:2000334 |
Process |
Positive regulation of blood microparticle formation |
IEA |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P16671 |
Protein name |
Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36) |
Protein function |
Multifunctional glycoprotein that acts as receptor for a broad range of ligands. Ligands can be of proteinaceous nature like thrombospondin, fibronectin, collagen or amyloid-beta as well as of lipidic nature such as oxidized low-density lipoprotein (oxLDL), anionic phospholipids, long-chain fatty acids and bacterial diacylated lipopeptides. They are generally multivalent and can therefore engage multiple receptors simultaneously, the resulting formation of CD36 clusters initiates signal transduction and internalization of receptor-ligand complexes. The dependency on coreceptor signaling is strongly ligand specific. Cellular responses to these ligands are involved in angiogenesis, inflammatory response, fatty acid metabolism, taste and dietary fat processing in the intestine (Probable). Binds long-chain fatty acids and facilitates their transport into cells, thus participating in muscle lipid utilization, adipose energy storage, and gut fat absorption (By similarity) (PubMed:18353783, PubMed:21610069). In the small intestine, plays a role in proximal absorption of dietary fatty acid and cholesterol for optimal chylomicron formation, possibly through the activation of MAPK1/3 (ERK1/2) signaling pathway (By similarity) (PubMed:18753675). Involved in oral fat perception and preferences (PubMed:22240721, PubMed:25822988). Detection into the tongue of long-chain fatty acids leads to a rapid and sustained rise in flux and protein content of pancreatobiliary secretions (By similarity). In taste receptor cells, mediates the induction of an increase in intracellular calcium levels by long-chain fatty acids, leading to the activation of the gustatory neurons in the nucleus of the solitary tract (By similarity). Important factor in both ventromedial hypothalamus neuronal sensing of long-chain fatty acid and the regulation of energy and glucose homeostasis (By similarity). Receptor for thombospondins, THBS1 and THBS2, mediating their antiangiogenic effects (By similarity). As a coreceptor for TLR4:TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, interacts with the heterodimer TLR4:TLR6, the complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion, through the priming and activation of the NLRP3 inflammasome (By similarity) (PubMed:20037584). Selective and nonredundant sensor of microbial diacylated lipopeptide that signal via TLR2:TLR6 heterodimer, this cluster triggers signaling from the cell surface, leading to the NF-kappa-B-dependent production of TNF, via MYD88 signaling pathway and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (By similarity) (PubMed:16880211). ; (Microbial infection) Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and the internalization of particles independently of TLR signaling. |
PDB |
5LGD
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF01130 |
CD36 |
14 → 463 |
CD36 family |
Family |
|
Sequence |
|
Sequence length |
472 |
Interactions |
View interactions |
|
|